NCT04164199 2026-03-16Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced MalignanciesBeOne MedicinesPhase 3 Enrolling by invitation430 enrolled
NCT05171335 2022-09-21Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma PatientsThe Methodist Hospital Research InstitutePhase 2 Enrolling by invitation50 enrolled